CACrown ArchivesThe cinema collection
Menu
Research dossier · History & Society

MagForce

German company

Layered newspapers, civic records and oral-history reels arranged as chronological evidence
History and societyInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionSep 10, 2026
Entity authorityQ48966228
Source-derived summary

MagForce AG is a publicly traded German company based in Berlin, Germany that develops medical devices that generate magnetic hyperthermia to treat cancer. The company was founded in 1997 as a spin-off from Charité.

The medical technology company conducts research in the field of nano medicine. It was the first company to receive European authorisation for a medical device containing nanoparticles, in 2010.

History

MagForce was founded in 1997 by Berlin biologist Andreas Jordan and biology engineer Regina Scholz, with Peter Heinrich later stepping in to manage the company.

MagForce AG was listed on the Frankfurt Stock Exchange in 2007. Having developed their NanoTherm, NanoPlan, and NanoActivator treatment systems, they received EU-wide certification (CE mark) and their first authorisation, specifically for the treatment of glioblastoma in 2010,

By 2013, sales of the system were poor; one reason for that was that the company had been run with little money, raising only about 11 million euros by 2010, and had scant clinical trial with which to convince oncologists that its system was effective and safe. The CEOs, Hoda Tawfik and Christian von Volkmann, re-evaluated the company's strategy, and raised 33.3 million euros, and used about half of that to retire debt. In September 2013, American Ben Lipps, who had previously led the DAX-listed Fresenius Medical Care Group, took over as the company's CEO. Lipps had played a crucial role in the widespread market adoption of dialysis procedures and was drawn to MagForce by his enthusiasm for innovative technology. In an interview with Die Welt, Lipps expressed optimism about MagForce's future, stating the company was" on the path to becoming a successful and highly profitable global player in oncology, with the potential to significantly improve the lives of cancer patients".

Editorial summary

The public source identifies “MagForce” as german company. This brief keeps that definition visible, then builds a research path around MagForce, German and company.

Editorial reviewMost valuable as an event-and-institution map that identifies actors, dates and record creators for deeper historical inquiry. The current lead gives the account dated anchors—1997, 2010, 2007, 2013—that can be checked directly. The linked authority record independently contributes the date 1997-01-01. Its value is orientation rather than verdict, with MagForce, German and company providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “MagForce”, the useful work is to connect “german company” to the records capable of establishing context and consequence.

Evidence profile

Chronology, provenance and viewpoint should be read together before a broad social or political interpretation is accepted. The source revision retrieved here is dated Sep 10, 2026. The linked authority identifier is Q48966228. 2 of 2 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1997, 2010, 2007 and 2013.

Critical limits

Official terminology may obscure informal participation, dissent or communities documented only indirectly. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.

Best used for
  • Event chronology
  • Institutional context
  • Locating named record creators
Verify next

Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.

Three-step research path

  1. Establish the record: confirm the title “MagForce”, its source revision and the description used here.
  2. Expand the search: follow MagForce primary sources, MagForce archive and MagForce research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “MagForce”?
  2. Who created the surviving record, and for what administrative purpose?
  3. What chronology connects this entry to wider political or social change?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from MagForce” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.